727 FinancePANews October 21 news, according to an official OpenAI announcement, OpenAI has acquired Orchestra Bio, a drug R&D collaboration platform. The platform helps biopharmaceutical teams coordinate complex drug development processes, allowing scientists and project leads to delegate the monitoring and tracking of research and trials to AI agents. OpenAI stated that it will integrate Orchestra's team and technology with Rosalind, its life sciences research AI model and tool, to help new therapies reach patients faster.
OpenAI acquires drug R&D collaboration platform Orchestra Bio
İlgili haberler
Finansman Haftalık | Kalshi, Sequoia Capital ve Wellington Management liderliğinde 1 milyar dolarlık G Serisi finansman turunu tamamladı.
Kalshi, 1 milyar dolarlık G Serisi finansman turunu tamamlayarak 40 milyar dolarlık bir post-money değerlemeye ulaştı; bu, bu yıl Mayıs ayındaki 22 milyar dolar...